United States Diabetes Supplement Market Insight
Published: 18 May 2026 | Report Format: Electronic (PDF)
US Diabetes Supplement market size is growing at a 8.02% CAGR, driven by increasing prevalence of diabetes, rising consumer awareness regarding preventive healthcare, and growing adoption of nutritional supplements for blood sugar management.
U.S. Diabetes Supplement Market Insights Forecasts to 2035
- The US Diabetes Supplement Market Size Was Estimated at USD 1.60 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.02% from 2025 to 2035
- The US Diabetes Supplement Market Size is Expected to Reach USD 3.46 Billion by 2035
Notable Insights for U.S. Diabetes Supplement Market
- By service type, the multi-ingredient supplements segment dominated the market, generating approximately USD 0.95 Billion in revenue in 2024.
- By application, the blood sugar management segment is expected to witness the fastest growth, supported by increasing demand for preventive and adjunct diabetes care solutions.
- Approximately 63% of consumers prefer supplements for preventive health management, while nearly 58% of diabetic patients use nutritional supplements alongside conventional therapies, enhancing overall disease management. Additionally, the US accounts for over 21% share of the global diabetes supplements market in 2024, reflecting strong adoption.
- Rising prevalence of diabetes and lifestyle disorders is strengthening the US diabetes supplement market, as over 40 Million Americans are affected by diabetes, driving demand for supportive nutritional solutions and functional supplements.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Diabetes Supplement market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Diabetes Supplement Market
- Abbott Laboratories
- Nature’s Bounty (Nestle Health Science)
- Amway Corporation
- Herb Pharm
- Garden of Life
- NOW Foods
- Solgar Inc.
- Glanbia plc
- Others
Recent Developments:
- In March 2026, Abbott Laboratories expanded its diabetes nutrition portfolio with clinically tested formulations designed to support blood glucose control and metabolic health, strengthening its presence in the US therapeutic nutrition segment.
- In June 2024, Nestle Health Science (Nature’s Bounty) introduced plant-based diabetes support supplements enriched with vitamins, minerals, and botanical extracts, enhancing product innovation and meeting growing demand for natural health solutions.
Market Segmentation:
United States Diabetes Supplement Market, By Product Type
- Multi-ingredient Supplements
- Single-ingredient Supplements
United States Diabetes Supplement Market, By Application
- Blood Sugar Management
- Weight Management
- General Wellnesss
United States Diabetes Supplement Market, By End User
- Adults
- Geriatric Population
- Others
Expert Views:
The US diabetes supplement market will experience substantial growth because people understand health better, and diabetes cases continue to increase. Experts predict that multi-ingredient supplements, together with blood sugar management applications, will lead the market, while personalized nutrition innovations with herbal formulations and clinically validated ingredients will enhance product performance to achieve permanent market growth.